Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L606 (MIMI_L606)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized Protein L606 (MIMI_L606)

Acanthamoeba polyphaga Mimivirus (APMV) is a giant virus known to infect amoeba . Its large DNA genome encodes for nearly 1,000 proteins . Among these is the uncharacterized protein L606 (MIMI_L606), which is the focus of this article. Recombinant MIMI_L606 is produced using genetic engineering techniques, typically in E. coli, for research purposes .

Basic Information

FeatureDescription
Full NameRecombinant Full Length Acanthamoeba polyphaga Mimivirus Uncharacterized Protein L606(MIMI_L606) Protein, His-Tagged
Source (Host)E. coli
SpeciesAPMV
TagHis-Tag
Protein LengthFull Length (1-186 amino acids)
Cat.No.RFL27189AF

Production and Availability

Recombinant MIMI_L606 is often produced in E. coli and tagged with histidine (His) . The His-tag facilitates purification using affinity chromatography . This recombinant protein is available for life science research from some commercial sources, who state that the protein products are rigorously tested to meet demanding research needs .

Protein Structure

Proteins have four levels of structure: primary, secondary, tertiary, and quaternary . The primary structure is the amino acid sequence . The folding of the polypeptide chain leads to secondary structures such as alpha-helices and beta-pleated sheets . These secondary structures are found in both globular and fibrous proteins and play a critical structural role .

Function and Interactions

MIMI_L606 has several biochemical functions and interacts with various proteins and molecules, as detected by methods such as yeast two-hybrid assays, co-immunoprecipitation (co-IP), and pull-down assays .

Role in Mimivirus Lifecycle

Studies have explored the proteins present within the Mimivirus virion and their roles in the early stages of infection . Research has identified several uncharacterized proteins, including L442, L724, L829, and R387, along with a putative GMC-type oxidoreductase R135, which are believed to be essential for DNA-mediated APMV generation .

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes; we will accommodate your request whenever possible.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its inclusion in the manufacturing process.
Synonyms
MIMI_L606; Uncharacterized protein L606
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-186
Protein Length
full length protein
Species
Acanthamoeba polyphaga mimivirus (APMV)
Target Names
MIMI_L606
Target Protein Sequence
MSYLTKYIDYFKSFTIMENPTESSRRDMEILVKNISSSLTTFTRDPIGMVVSSLMLLLVY FCFATTFIYKGISLFIPSYCIYHVLNSNTNQEVKYKNILTYFFIYSHIEFISDILETVGF GLLHLKIALVIVLLYTVHYRNEWLEMIYNKIVYFDTIGFYTLFFTYSRLIQEYNKFRQTV KIKKNE
Uniprot No.

Target Background

Database Links

KEGG: vg:9925244

Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is the basic structural information available for MIMI_L606?

MIMI_L606 is an uncharacterized protein from Acanthamoeba polyphaga mimivirus with UniProt accession number Q5UP70. The amino acid sequence consists of 194 amino acids with the following sequence: MSYLTKYDYFKSFTIMENPTESSR RDMEILVKNISSSLTTFTRDPIGMVVSSLM LLLVYFCFATTFIYKGISLFIPSYCIYHVLNSNTN QEVKYKNILTYFFIYSHIEFISDILETVGFGLLHLKI ALVIVLLYTVHYRNEWLEMIYNKIVYFDTIGFYT LFFTYSRLIQEYNKFRQTVKIKKNE .

The protein appears to contain hydrophobic regions that may indicate transmembrane domains, as suggested by the prevalence of hydrophobic amino acids in portions of the sequence. This structural characteristic presents specific challenges for expression and purification that researchers should consider when designing experimental workflows.

What expression systems are most suitable for MIMI_L606?

The expression of MIMI_L606, like many viral proteins with hydrophobic regions, presents specific challenges. Based on general recombinant protein expression principles, researchers should consider:

The selection should be guided by the hydrophobicity analysis of the protein sequence and the intended downstream applications. For functional studies, prioritizing native conformation over yield might be necessary.

What purification methods optimize yield while maintaining MIMI_L606 structural integrity?

Purification of MIMI_L606 requires careful consideration of the protein's predicted membrane association. Based on established methodologies:

  • Affinity chromatography: Using tags such as His-tag or MBP fusion systems can facilitate initial capture. The search results indicate that similar Mimivirus proteins have been successfully purified using MBP fusion with C-terminal 10X histidine epitope tags followed by successive amylose and nickel-nitrilotriacetic acid columns .

  • Buffer optimization: Given the hydrophobic regions in MIMI_L606, buffers containing mild detergents (0.1% DDM, CHAPS, or Triton X-100) may help maintain solubility without denaturing the protein.

  • Storage conditions: The protein is optimally stored in Tris-based buffer with 50% glycerol at -20°C or -80°C for extended storage, with working aliquots maintained at 4°C for up to one week . Repeated freeze-thaw cycles should be avoided to maintain structural integrity.

How can researchers assess the potential function of MIMI_L606 based on sequence homology?

Despite being uncharacterized, computational approaches can provide insights into potential functions:

  • Multiple sequence alignment: Compare L606 against other Mimivirus proteins and viral/host proteins using tools like BLAST, HMMER, and structural prediction algorithms.

  • Domain analysis: Though no specific domains are mentioned in the available data, researchers should perform hidden Markov model searches against domain databases (Pfam, SMART) to identify potential functional domains.

  • Structural prediction: Given that L606 is uncharacterized, using AlphaFold2 or RoseTTAFold to predict structural features may reveal functional clues by identifying structural similarities to characterized proteins.

  • Phylogenetic analysis: Constructing phylogenetic trees of related sequences can place L606 in evolutionary context, potentially revealing functional relationships.

A particular focus should be placed on comparison with other characterized Mimivirus proteins, such as L375, which has demonstrated mRNA decapping activity . This comparative approach may reveal if L606 belongs to a functional group of proteins involved in viral replication or host interaction.

What experimental approaches can determine if MIMI_L606 is essential for Mimivirus replication?

Determining the essentiality of L606 requires sophisticated virological techniques:

  • DNA transfection and complementation assays: Similar to experiments described for other Mimivirus proteins, microinjection of Mimivirus DNA into Acanthamoeba castellanii cells with L606 gene knockouts or modifications can reveal if the protein is essential for virion production .

  • Temporal expression analysis: RT-PCR or RNA-Seq during different phases of infection can determine when L606 is expressed, providing clues about its role in the viral life cycle.

  • Subcellular localization: Immunofluorescence microscopy using antibodies against recombinant L606 can reveal where the protein localizes during infection (viral factory, host cytoplasm, etc.).

  • Protein-protein interaction studies: Techniques like co-immunoprecipitation, similar to those used for NME1-DNM2 interactions , can identify viral or host proteins that interact with L606, suggesting functional pathways.

The observation that L606 remains uncharacterized suggests that standard approaches have not yet definitively established its function, warranting more creative experimental designs that consider the protein's unique features.

How might researchers investigate potential post-translational modifications of MIMI_L606?

Post-translational modifications can significantly impact protein function and are often crucial for viral proteins:

Modification TypeDetection MethodSample PreparationAnalysis Approach
PhosphorylationLC-MS/MSTiO₂ enrichmentSite-specific quantification
GlycosylationGlycoprotein staining, Mass spectrometryPNGase F treatmentComparison of treated vs. untreated
UbiquitinationWestern blot, Mass spectrometryImmunoprecipitationK-ε-GG antibodies
Proteolytic processingSDS-PAGE, N-terminal sequencingTime-course analysisComparison to predicted mass

Given the observation that Mimivirus virions contain many proteins and RNA that may be involved in early stages of infection , investigating how post-translational modifications of L606 might regulate its activity during different infection phases could be particularly informative.

What controls should be included when studying MIMI_L606 protein-protein interactions?

Robust controls are essential for reliable protein-protein interaction studies:

  • Positive controls: Include known interacting protein pairs from Mimivirus, such as those identified in previous studies. While specific L606 interactors aren't described in the search results, researchers might use other characterized Mimivirus protein interactions as system validation.

  • Negative controls: Use non-related proteins that should not interact with L606, such as bacterial proteins or denatured L606.

  • Tag-only controls: Since many interaction studies use tagged proteins, include the tag alone (e.g., MBP or His-tag) to rule out tag-mediated interactions .

  • Reciprocal co-immunoprecipitation: Perform two-way co-immunoprecipitation, similar to the approach used for NME1 and DNM2 interaction validation , to confirm specific binding.

  • Competition assays: Introduce increasing amounts of untagged protein to compete with tagged protein, demonstrating specificity of interactions.

Researchers should also consider that L606's potential membrane association may necessitate specialized approaches for detecting interactions with other membrane proteins, possibly requiring detergent-based methods or membrane-specific proximity labeling techniques.

How can researchers validate the expression and activity of recombinant MIMI_L606?

Validation of recombinant L606 expression and activity requires multiple complementary approaches:

  • Protein expression confirmation:

    • SDS-PAGE with Coomassie staining to confirm molecular weight (expected ~87 kDa for MBP-L606-His fusion, based on comparable fusion proteins)

    • Western blot using anti-tag antibodies or specific antibodies against L606 if available

    • Mass spectrometry for definitive sequence confirmation

  • Functionality assessment:

    • Given that L606 is uncharacterized, researchers might need to develop functional assays based on predictions from bioinformatic analyses

    • If structural analysis suggests enzymatic activity, appropriate biochemical assays should be developed

    • For potential membrane proteins, liposome association or membrane integration assays may be relevant

  • Structural integrity validation:

    • Circular dichroism spectroscopy to assess secondary structure

    • Limited proteolysis to evaluate folding quality

    • Thermal shift assays to determine stability

Since L606 functions remain unknown, researchers should design multiple parallel validation approaches based on the most likely functional categories suggested by sequence and structural predictions.

What methods can identify the role of MIMI_L606 during different stages of Mimivirus infection?

Understanding the temporal aspects of L606 function requires time-resolved approaches:

  • Temporal expression profiling:

    • RT-qPCR to quantify L606 mRNA levels at different infection timepoints

    • Western blot analysis of infected cells at regular intervals to track protein levels

    • Ribosome profiling to determine when L606 is actively translated

  • Functional disruption at specific timepoints:

    • Temperature-sensitive mutants that can be inactivated at specific stages

    • Inducible expression systems for complementation studies

    • Small molecule inhibitors if binding sites can be identified through structural studies

  • Localization throughout infection cycle:

    • Time-lapse fluorescence microscopy with fluorescently tagged L606

    • Immunofluorescence staining at fixed timepoints

    • Subcellular fractionation coupled with Western blot analysis

Given that the early stages of Mimivirus infection involve proteins and RNA within the virion , special attention should be paid to whether L606 is packaged into mature virions and if it functions immediately upon infection or later in the replication cycle.

How should researchers address contradictory results about MIMI_L606 function from different methodologies?

Contradictory results are common in the study of uncharacterized proteins and require systematic resolution approaches:

  • Source verification: Determine if contradictions arise from differences in:

    • Protein preparation methods (expression systems, purification protocols)

    • Experimental conditions (buffer components, pH, temperature)

    • Detection methods (direct vs. indirect measurements)

  • Methodology limitations assessment:

    • Evaluate assumptions underlying each method

    • Consider artifacts specific to particular techniques

    • Assess sensitivity and specificity parameters of each approach

  • Integration framework:

    • Apply Bayesian probability approaches to weigh evidence from multiple sources

    • Utilize MiMI (Michigan Molecular Interactions) principles to highlight when "facts are corroborated by different datasets, and when facts are contradicted among datasets"

    • Track provenance of each data point to facilitate understanding of contradictions

  • Targeted validation experiments:

    • Design experiments specifically addressing the contradiction points

    • Use orthogonal methods to triangulate results

    • Perform dose-response or time-course studies to reconcile apparently contradictory findings

What computational methods can help integrate MIMI_L606 data with broader Mimivirus protein networks?

Integration of L606 data into broader protein networks requires sophisticated computational approaches:

  • Network construction methods:

    • Protein-protein interaction networks based on experimental data

    • Co-expression networks from transcriptomic data

    • Functional association networks from genomic context analysis

  • Data integration platforms:

    • Michigan Molecular Interactions (MiMI) framework to integrate multiple data sources while preserving provenance information

    • Cytoscape for visualization and analysis of molecular interaction networks

    • STRING database for predicted functional associations

  • Analysis approaches:

    • Module detection to identify functional clusters

    • Pathway enrichment analysis to place L606 in biological contexts

    • Centrality measures to assess the importance of L606 in network architecture

  • Temporal dynamics modeling:

    • Ordinary differential equation models of protein interaction dynamics

    • Stochastic simulation algorithms for low-abundance proteins

    • Agent-based models for spatiotemporal dynamics during infection

By placing L606 within these networks, researchers can generate testable hypotheses about its function even with limited direct experimental data, guiding future experimental design.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.